Sign in or create an account to add this stock to your watchlist.
About PharmaGap (CVE:GAP)
PharmaGap Inc. (PharmaGap) is a development-stage company. The Company is principally engaged in drug development and out-licensing of drug compounds. The Company is focused on the development of novel drugs for treatment of cancer and other human disease conditions. PharmaGap's lead drug compound, GAP-107B8, is in the pre-clinical testing stage and has shown in vitro and in vivo efficacy in selected cancer types. During the year ended December 31, 2011, the Company commenced specific programs to further elucidate information regarding the pharmacokinetics and toxicity profiles of GAP-107B8. A program to develop liposomal delivery formulations of GAP-107B8 in order to optimize the delivery and safety of the drug compound was completed during 2011. The Company is developing GAP-107B8 for first clinical trials in ovarian cancer, using the intra-peritoneal route of administration.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:GAP
CUSIPN/A
WebN/A
Phone+1-613-2873118
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
PharmaGap (CVE:GAP) Frequently Asked Questions
What is PharmaGap's stock symbol?
PharmaGap trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GAP."
Has PharmaGap been receiving favorable news coverage?
News headlines about GAP stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PharmaGap earned a media sentiment score of 0.06 on Accern's scale. They also gave press coverage about the company an impact score of 47.11 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of PharmaGap?
Shares of GAP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How can I contact PharmaGap?
PharmaGap's mailing address is 1000 Innovation Drive, Suite 400, OTTAWA, ON K2K 2K7, Canada. The company can be reached via phone at +1-613-2873118.
MarketBeat Community Rating for PharmaGap (GAP)
MarketBeat's community ratings are surveys of what our community members think about PharmaGap and other stocks. Vote "Outperform" if you believe GAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
PharmaGap (CVE:GAP) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 5/21/2016 forward)
PharmaGap (CVE:GAP) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
PharmaGap (CVE GAP) Insider Trading and Institutional Ownership History
PharmaGap (CVE GAP) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
PharmaGap (CVE GAP) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
PharmaGap (CVE:GAP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
PharmaGap (CVE GAP) Stock Chart for Monday, May, 21, 2018
Loading chart…
